Partner: CNRS

Does acetaminophen blunt cancer immunotherapy? Plasma evidence links paracetamol to worse checkpoint-inhibitor outcomes

Why melanoma escapes BRAF inhibitors — the AhR transcription factor behind resistance and relapse